Recap: AbCellera Biologics Q1 Earnings

AbCellera Biologics ABCL reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

AbCellera Biologics reported in-line EPS of $-0.14 versus an estimate of $-0.14.

Revenue was down $304.39 million from the same period last year.

Last quarter the company missed on EPS by $0.1 which was followed by a 1.12% drop in the share price the next day.

Here's a look at AbCellera Biologics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0	0.04	-0.02	0.33
EPS Actual	-0.1	0.08	-0.02	0.54
Revenue Estimate	50.80M	74.95M	53.59M	194.67M
Revenue Actual	21.55M	101.38M	45.92M	316.58M

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar